UK-Sweden $278 Billion Pharmaceutical Giant AstraZeneca to Delist from Nasdaq in 2026 January (30/1/26) & Joins NYSE in Direct Listings of Ordinary Shares & Debts in 2026 February (2/2/25) from Nasdaq Current American Depositary Receipts (ADR) Structure, Currently Listed on London Stock Exchange (LSE) & Nasdaq Stockholm (STO), Current Market Value at $278 Billion, Share Price -1.7% YTD, +20.8% Last 12 Months & +71.7% Last 5 Years

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets? Caproasia - Learn more

Caproasia Access | Events | Summits | Register Events | The Financial Centre
The 2026 Investment Day | 2026 Family Office Summits | Family Office Circle

This site is for accredited investors, professional investors, investment managers and financial professionals only. You should have assets around $3 million to $300 million or managing $20 million to $30 billion.

---

UK-Sweden $278 Billion Pharmaceutical Giant AstraZeneca to Delist from Nasdaq in 2026 January (30/1/26) & Joins NYSE in Direct Listings of Ordinary Shares & Debts in 2026 February (2/2/25) from Nasdaq Current American Depositary Receipts (ADR) Structure, Currently Listed on London Stock Exchange (LSE) & Nasdaq Stockholm (STO), Current Market Value at $278 Billion, Share Price -1.7% YTD, +20.8% Last 12 Months & +71.7% Last 5 Years

21st January | Hong Kong

UK-Sweden pharmaceutical giant AstraZeneca ($262 billion market value) to delist from Nasdaq in 2026 January (30/1/26) & joins NYSE in direct listings of ordinary shares & debts in 2026 February (2/2/25) from current American Depositary Receipts (ADR) structure.  AstraZeneca is currently listed on London Stock Exchange (LSE) & Nasdaq Stockholm (STO).  AstraZeneca current market value at $278 billion, share price -1.7% YTD, +20.8% last 12 months & +71.7% last 5 years.  In 2025 November, AstraZeneca shareholders voted to approve for a New York Stock Exchange (NYSE) direct listing in 2026 February (2/2/25) from current American Depositary Receipts (ADR) structure.  In 2025 October, AstraZeneca was planning for a New York Stock Exchange (NYSE) direct listing in 2026 February (2/2/25) from current American Depositary Receipts (ADR) structure.  AstraZeneca shareholders will vote on 3rd November 2025 for the NYSE direct listing. 

“ UK-Sweden $278 Billion Pharmaceutical Giant AstraZeneca to Delist from Nasdaq in 2026 January (30/1/26) & Joins NYSE in Direct Listings of Ordinary Shares & Debts in 2026 February (2/2/25) from Nasdaq Current American Depositary Receipts (ADR) Structure, Currently Listed on London Stock Exchange (LSE) & Nasdaq Stockholm (STO), Current Market Value at $278 Billion, Share Price -1.7% YTD, +20.8% Last 12 Months & +71.7% Last 5 Years “

- Article continues below -

Quick Links, Ads & Announcements
Caproasia Access | Events | Summits | Register Events | The Financial Centre
The 2026 Investment Day | 2026 Family Office Summits | Family Office Circle

Intelligence at your fingertips
Get Started ($29 per year) : Click here
Caproasia Subscription ($680 yearly | $70 monthly): Click here

The 2026 Investment Day
Hong Kong | Singapore
March / July / Sept / Oct / Nov
Private Equity, Hedge Funds, Boutique Funds, Private Markets & more. Join 20+ CIOs & Senior investment team, with > 60% single family offices with $300 million AUM. Taking place in Hong Kong and in Singapore. Every March, April, July, Sept, Oct & Nov.
Visit | Register here

The 2026 Family Office Summit
9th / 16th April & 15th Oct Hong Kong Ritz Carlton | 23rd / 30th April & 5th Nov Singapore Amara Sanctuary Resort
Join 60 single family offices & family office professionals in Hong Kong & Singapore
Links: 2026 Family Office Summit | Register here

2026 Investment / Alternatives Summit
March / Oct / Nov in Hong Kong & Singapore
Join leading asset managers, hedge funds, boutique funds, private equity, venture capital & real estate firms in Hong Kong, Singapore & Asia-Pacific at the Investment / Alternatives Summit. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

2026 Private Wealth Summit
April / Oct / Nov in Hong Kong & Singapore
Join CEOs, CIOs, Head of Private Banking, Head of Family Offices & Product Heads at The Private Wealth Summit.  Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

UK-Sweden $262 Billion Pharmaceutical Giant AstraZeneca Shareholders Voted to Approve NYSE Direct Listing in 2026 February (2/2/25) from Current American Depositary Receipts (ADR) Structure, Currently Listed on London Stock Exchange (LSE) & Nasdaq Stockholm (STO), Current Market Value at $262 Billion, Share Price +21.1% YTD, +30% Last 12 Months & +52% Last 5 Years

8th November – UK-Sweden pharmaceutical giant AstraZeneca ($262 billion market value) shareholders have voted to approve for a New York Stock Exchange (NYSE) direct listing in 2026 February (2/2/25) from current American Depositary Receipts (ADR) structure.  AstraZeneca is currently listed on London Stock Exchange (LSE) & Nasdaq Stockholm (STO).  AstraZeneca current market value at $262 billion, with share price +21.1% YTD, +30% last 12 months & +52% last 5 years.    In 2025 October, AstraZeneca was planning for a New York Stock Exchange (NYSE) direct listing in 2026 February (2/2/25) from current American Depositary Receipts (ADR) structure.  AstraZeneca shareholders will vote on 3rd November 2025 for the NYSE direct listing.  AstraZeneca current market value at $246 billion, with share price +11.6% YTD, +0.5% last 12 months & +40.7% last 5 years.  

UK-Sweden $246 Billion Pharmaceutical Giant AstraZeneca Plans NYSE Direct Listing in 2026 February (2/2/25) from Current American Depositary Receipts (ADR) Structure, Currently Listed on London Stock Exchange (LSE) & Nasdaq Stockholm (STO), Shareholders to Vote on 3rd November 2025, Current Market Value at $246 Billion, Share Price +11.6% YTD, +0.5% Last 12 Months & +40.7% Last 5 Years

1st October – UK-Sweden pharmaceutical giant AstraZeneca ($246 billion market value) is planning for a New York Stock Exchange (NYSE) direct listing in 2026 February (2/2/25) from current American Depositary Receipts (ADR) structure.  AstraZeneca is currently listed on London Stock Exchange (LSE) & Nasdaq Stockholm (STO).  AstraZeneca shareholders will vote on 3rd November 2025 for the NYSE direct listing.  AstraZeneca current market value at $246 billion, with share price +11.6% YTD, +0.5% last 12 months & +40.7% last 5 years.

Managing $20 million to $3 billion. Investing $3 million to $300 million.
For Investment Managers, Hedge Funds, Boutique Funds, Private Equity, Venture Capital, Professional Investors, Family Offices, Private Bankers & Advisors, sign up today. Subscribe to Caproasia and receive the latest news, data, insights & reports, events & programs daily at 2 pm.

Join Events & Find Services
Join Investments, Private Wealth, Family Office events in Hong Kong, Singapore, Asia-wide. Find hard-to-find $3 million to $300 million financial & investment services at The Financial Centre | TFC. Find financial, investment, private wealth, family office, real estate, luxury investments, citizenship, law firms & more.  List hard-to-find financial & private wealth services.

Have a product launch? Promote a product or service? List your service at The Financial Centre | TFC. Join interviews & editorial and be featured on Caproasia.com or join Investments, Private Wealth, Family Office events. Contact us at [email protected] or [email protected]

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets?

Quick Links

Caproasia Access | Events | Summits | Register Events | The Financial Centre
The 2026 Investment Day | 2026 Family Office Summits | Family Office Circle

Web links may be disabled on mobile for security.
Please click on desktop.

---

New to Caproasia
Learn More | Sign Up | Subscribe | Register Events

Caproasia Users

• Manage $20 million to $30 billion of assets
• Invest $3 million to $300 million
• Advise institutions, billionaires, UHNWs & HNWs

Caproasia Platforms | 11,000 Investors & Advisors

• Caproasia.com
• Caproasia Access
• Caproasia Events
• The Financial Centre | Find Services
• Membership
• Family Office Circle
• Professional Investor Circle
• Investor Relations Network

Monthly Roundtable & Networking

• Professional Investor
• Family Office
• HNW Partnership

Family Office Programs

• Family Office Circle
• Family Office Networking
• Family Office Roundtable
• The Family Office Summit

The 2026 Investment Day

• March - Hong Kong
• March - Singapore
• April - Hong Kong
• April - Singapore
• July - Hong Kong
• July - Singapore
• Sept- Hong Kong
• Sept - Singapore
• Oct- Hong Kong
• Nov - Singapore
• Visit: The Investment Day | Register: Click here

Caproasia Summits

• The Institutional Investor Summit
• The Investment / Alternatives Summit
• The Private Wealth Summit
• The Family Office Summit
• The CEO & Entrepreneur Summit
• The Capital Markets Summit
• The ESG / Sustainable Investment Summit

Contact Us

For Enquiries, Membership
[email protected], [email protected]

For Listing, Subscription
[email protected], [email protected]

For Press Release, send to:
[email protected]

For Events & Webinars
[email protected]

For Media Kit, Advertising, Sponsorships, Partnerships
[email protected]

For Research, Data, Surveys, Reports
[email protected]

For General Enquiries
[email protected]

---

Caproasia | Driving the future of Asia
a financial information technology co.
since 2014

---